Antagonism of marihuana effects by indomethacin in humans
- 31 December 1991
- journal article
- clinical trial
- Published by Elsevier in Life Sciences
- Vol. 48 (6) , 507-515
- https://doi.org/10.1016/0024-3205(91)90465-n
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Scopolamine disruption of septo-hippocampal activity and classical conditioning.Behavioral Neuroscience, 1989
- The central neuropharmcology of psychotropic cannabinoidsPharmacology & Therapeutics, 1988
- A major metabolite of Δ1-tetrahydrocannabinol reduces its cataleptic effect in miceCellular and Molecular Life Sciences, 1987
- Affinity for the dopamine D2 receptor predicts neuroleptic potency in decreasing the speed of an internal clockPharmacology Biochemistry and Behavior, 1986
- Prostaglandins and Cannabis—VIII. Elevation of Phospholipase A2 Activity by Cannabinoids in Whole Cells and Subcellular PreparationsThe Journal of Clinical Pharmacology, 1981
- Gabaergic mediation in the inhibition of hippocampal acetylcholine turnover rate elicited by Δ9-tetrahydrocannabinolNeuropharmacology, 1979
- Influence of marihuana on storage and retrieval processe in memoryMemory & Cognition, 1973
- Effects of various psychotomimetic agents on the eeg and acetylcholine release from the cerebral cortex of brainstem transected catsNeuropharmacology, 1972
- Effect of an extract of cannabis and of some cannabinols on catecholamine metabolism in rat brain and heartInflammation Research, 1970
- THE CHOLINERGIC LIMBIC SYSTEM: PROJECTIONS TO HIPPOCAMPAL FORMATION, MEDIAL CORTEX, NUCLEI OF THE ASCENDING CHOLINERGIC RETICULAR SYSTEM, AND THE SUBFORNICAL ORGAN AND SUPRA-OPTIC CRESTBrain, 1967